postbiotic
With nearly half of European consumers taking supplements for general wellbeing, the potential for targeted innovation is vast, especially on “biotics” products.
Gastroenterology
Sponsored by
Postbiotics can selectively enhance beneficial microbes, offering a safe and effective microbiome-support strategy.
The study revealed that MS-20 dramatically improved treatment outcomes, tripling the objective response rate (ORR) to 75% when combined with Keytruda.
The transaction represents an enterprise value of €275 million, an estimated 2023 EV/EBITDA multiple of 18x.
